Analysis and Data Utilization

The Identification of Migraine Screener (ID Migraine™) is a brief, reliable, and scientifically validated screening instrument designed for the rapid identification of individuals who are likely to suffer from migraine. Developed by Richard B. Lipton and colleagues, the questionnaire was created to facilitate the early recognition of migraine in primary care and other clinical settings, particularly among patients presenting with recurrent headaches who have not yet received a formal diagnosis. The instrument consists of three simple Yes/No questions assessing the most characteristic symptoms of migraine, including nausea, photophobia, and migraine-related disability, specifically whether headaches interfere with normal daily activities. Owing to its high sensitivity and specificity, the ID Migraine™ is widely used as a first-line screening tool to identify patients who should undergo a more comprehensive neurological evaluation based on the diagnostic criteria of the International Classification of Headache Disorders (ICHD-3). It is important to emphasize that the instrument is intended as a screening tool rather than a definitive diagnostic test, supporting healthcare professionals in recognizing patients at increased risk of migraine and facilitating timely referral and treatment. The present description expands upon the information contained in the uploaded document.

Data analysis using the ID Migraine™ typically begins with descriptive statistical analyses, including frequencies, percentages, means, standard deviations, score distributions, and prevalence estimates based on the number of positive responses. Researchers commonly report the proportion of individuals classified as being at low, moderate, or high probability of migraine. Comparisons across demographic, clinical, or epidemiological groups may be performed using Chi-square (χ²) tests for categorical variables and independent-samples t-tests, one-way Analysis of Variance (ANOVA), Mann–Whitney U tests, or Kruskal–Wallis tests, depending on the characteristics and distribution of the collected data.

The psychometric evaluation of the ID Migraine™ includes assessment of diagnostic sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and overall diagnostic accuracy through Receiver Operating Characteristic (ROC) curve analysis and calculation of the Area Under the Curve (AUC). Additional psychometric properties include criterion validity, convergent validity through correlations with validated migraine instruments such as the Migraine Disability Assessment (MIDAS) and the Headache Impact Test (HIT-6), as well as test–retest reliability to evaluate the stability of responses over time.

Advanced statistical analyses may include Pearson or Spearman correlation analyses, binary logistic regression, multivariable regression models, ROC analysis, and Structural Equation Modeling (SEM) to investigate predictors of migraine probability, headache severity, attack frequency, migraine-related disability, health-related quality of life, healthcare utilization, and treatment outcomes.

The ID Migraine™ is widely used in primary healthcare, neurology, general practice, internal medicine, emergency medicine, occupational health, epidemiological research, and public health screening programs. It is particularly valuable for identifying individuals with undiagnosed migraine, reducing diagnostic delays, improving referral pathways, and supporting early evidence-based management.

The findings generated by the ID Migraine™ provide valuable information for neurologists, primary care physicians, general practitioners, nurses, researchers, occupational health professionals, and public health specialists, supporting evidence-based clinical decision-making, appropriate diagnostic referral, and improved management of patients with migraine.

Objective

The primary objective of the Identification of Migraine Screener (ID Migraine™) is to provide a rapid, reliable, and valid screening assessment for identifying individuals with a high probability of migraine. The instrument enables healthcare professionals to recognize patients who require further neurological evaluation, thereby reducing underdiagnosis, facilitating early intervention, and improving patient outcomes and quality of life.

Furthermore, the ID Migraine™ supports clinical and epidemiological research investigating migraine prevalence, diagnostic accuracy, healthcare utilization, headache-related disability, and treatment effectiveness.

Scoring

The Identification of Migraine Screener (ID Migraine™) consists of three Yes/No questions assessing characteristic migraine symptoms experienced during the previous three months.

Each “Yes” response receives 1 point, whereas each “No” response receives 0 points.

The total score ranges from 0 to 3.

• 0–1 positive responses: Low probability of migraine.
• 2 positive responses: Moderate probability of migraine, indicating that further clinical evaluation is recommended.
• 3 positive responses: High probability of migraine and a strong indication for comprehensive diagnostic assessment according to the International Classification of Headache Disorders (ICHD-3).

Interpretation of the results should always be performed in conjunction with the patient’s medical history, clinical examination, and current diagnostic guidelines established by the International Headache Society (IHS). The ID Migraine™ is intended as a screening instrument and should not be used as a substitute for a comprehensive medical diagnosis.

References (APA 7th Edition)

Headache Classification Committee of the International Headache Society. (2018). The International Classification of Headache Disorders (3rd ed.). Cephalalgia, 38(1), 1–211. https://doi.org/10.1177/0333102417738202

Lipton, R. B., Dodick, D., Sadovsky, R., Kolodner, K., Endicott, J., Hettiarachchi, J., & Harrison, W. (2003). A self-administered screener for migraine in primary care: The ID Migraine™ validation study. Neurology, 61(3), 375–382.

Lipton, R. B., Stewart, W. F., & Ryan, R. E. (1998). Validation of migraine diagnosis using a self-administered questionnaire. Headache: The Journal of Head and Face Pain, 38(6), 373–378.

Stewart, W. F., Lipton, R. B., Celentano, D. D., & Reed, M. L. (1992). Prevalence of migraine headache in the United States. JAMA, 267(1), 64–69.

Stewart, W. F., & Lipton, R. B. (1997). The ID Migraine™ Screener: A reliable and valid tool for identifying migraine. The Journal of Headache and Pain, 4(2), 110–114.